Nonghua Lü

8.4k total citations · 1 hit paper
200 papers, 6.1k citations indexed

About

Nonghua Lü is a scholar working on Surgery, Molecular Biology and Oncology. According to data from OpenAlex, Nonghua Lü has authored 200 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 148 papers in Surgery, 60 papers in Molecular Biology and 57 papers in Oncology. Recurrent topics in Nonghua Lü's work include Helicobacter pylori-related gastroenterology studies (75 papers), Pancreatitis Pathology and Treatment (60 papers) and Pancreatic and Hepatic Oncology Research (47 papers). Nonghua Lü is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (75 papers), Pancreatitis Pathology and Treatment (60 papers) and Pancreatic and Hepatic Oncology Research (47 papers). Nonghua Lü collaborates with scholars based in China, United States and Hong Kong. Nonghua Lü's co-authors include Zhen Yang, Yin Zhu, Wenting Xu, Cong He, Nianshuang Li, Yi Hu, Yaobin Ouyang, Aiping Bai, Chao Peng and Liang Xia and has published in prestigious journals such as Nature Communications, The Journal of Immunology and Gastroenterology.

In The Last Decade

Nonghua Lü

189 papers receiving 6.0k citations

Hit Papers

A new role for the PI3K/Akt signaling pathway in the epit... 2015 2026 2018 2022 2015 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nonghua Lü China 43 2.9k 2.4k 1.5k 1.2k 887 200 6.1k
Ulrich R. Fölsch Germany 49 2.8k 0.9× 2.6k 1.1× 2.2k 1.5× 931 0.8× 990 1.1× 207 7.6k
Ye Chen China 41 1.5k 0.5× 2.7k 1.1× 821 0.6× 765 0.6× 569 0.6× 237 5.6k
Shuji Terai Japan 40 2.6k 0.9× 1.8k 0.8× 814 0.6× 734 0.6× 556 0.6× 471 7.4k
Shunji Ishihara Japan 43 3.4k 1.1× 1.3k 0.5× 664 0.5× 966 0.8× 1.1k 1.3× 310 6.4k
Kazuhiko Nakao Japan 48 2.2k 0.8× 2.4k 1.0× 1.1k 0.7× 1.7k 1.4× 1.3k 1.5× 393 9.2k
Luís Bujanda Spain 52 3.4k 1.2× 2.8k 1.2× 2.5k 1.7× 1.7k 1.4× 397 0.4× 330 9.6k
Yoshikazu Kinoshita Japan 45 4.0k 1.4× 1.2k 0.5× 718 0.5× 1.1k 0.9× 1.2k 1.4× 322 6.9k
Jean‐Pierre Raufman United States 37 2.1k 0.7× 1.9k 0.8× 1.2k 0.8× 414 0.3× 267 0.3× 163 5.7k
Minhu Chen China 45 1.8k 0.6× 1.7k 0.7× 846 0.6× 658 0.5× 700 0.8× 208 6.0k
Masao Ichinose Japan 50 4.6k 1.6× 2.5k 1.1× 1.0k 0.7× 4.0k 3.3× 688 0.8× 198 9.1k

Countries citing papers authored by Nonghua Lü

Since Specialization
Citations

This map shows the geographic impact of Nonghua Lü's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nonghua Lü with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nonghua Lü more than expected).

Fields of papers citing papers by Nonghua Lü

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nonghua Lü. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nonghua Lü. The network helps show where Nonghua Lü may publish in the future.

Co-authorship network of co-authors of Nonghua Lü

This figure shows the co-authorship network connecting the top 25 collaborators of Nonghua Lü. A scholar is included among the top collaborators of Nonghua Lü based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nonghua Lü. Nonghua Lü is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Yanan, Nianshuang Li, Ziwen He, et al.. (2025). Helicobacter pylori activates DOPEY1 to promote p53 degradation through the USP7/TRIP12 axis in gastric tumorigenesis. Oncogene. 44(18). 1245–1258. 2 indexed citations
2.
Kuang, Maobin, Xin Xu, Xue-Yang Li, et al.. (2025). Lactate Dehydrogenase-to-Albumin Ratio as a Predictor of In-Hospital Mortality in Predicted Severe Acute Pancreatitis: Evidence from an 18-Year Cohort Study. Journal of Inflammation Research. Volume 18. 14927–14939.
5.
Ouyang, Yaobin, et al.. (2023). Research trends on vonoprazan‐based therapy for Helicobacter pylori eradication: A bibliometric analysis from 2015 to 2023. Helicobacter. 28(5). e13012–e13012. 5 indexed citations
7.
Liao, Qian, Ling Ding, Yu Chen, et al.. (2022). Pancreatic necrosis volume for predicting readmission and reintervention in acute necrotizing pancreatitis. European Journal of Radiology. 154. 110419–110419. 3 indexed citations
8.
He, Wenhua, Peng Chen, Yupeng Lei, et al.. (2022). Randomized controlled trial: neostigmine for intra-abdominal hypertension in acute pancreatitis. Critical Care. 26(1). 52–52. 15 indexed citations
9.
Hu, Yi, Yaobin Ouyang, Cong He, et al.. (2022). Analysis of oral microbiota alterations induced by Helicobacter pylori infection and vonoprazan‐amoxicillin dual therapy for Helicobacter pylori eradication. Helicobacter. 27(5). e12923–e12923. 8 indexed citations
10.
11.
Ouyang, Yaobin, Wenjing Zhang, Yao Wang, et al.. (2021). Effect of Helicobacter pylori eradication on hyperplastic gastric polyps: A systematic review and meta‐analysis. Helicobacter. 26(5). e12838–e12838. 9 indexed citations
12.
Chen, Hongyan, Yi Hu, Xinbo Xu, et al.. (2021). Upregulation of oncogene Activin A receptor type I by Helicobacter pylori infection promotes gastric intestinal metaplasia via regulating CDX2. Helicobacter. 26(6). e12849–e12849. 11 indexed citations
13.
Li, Nianshuang, et al.. (2021). Discovery and Validation of Novel Methylation Markers in Helicobacter pylori-Associated Gastric Cancer. Disease Markers. 2021. 1–11. 6 indexed citations
14.
Ouyang, Yaobin, Zhihao Zhu, Li Huang, et al.. (2021). Research Trends on Clinical Helicobacter pylori Eradication: A Bibliometric Analysis from 1983 to 2020. Helicobacter. 26(5). e12835–e12835. 6 indexed citations
15.
Li, Xueyang, Cong He, Nianshuang Li, et al.. (2020). The interplay between the gut microbiota and NLRP3 activation affects the severity of acute pancreatitis in mice. Gut Microbes. 11(6). 1774–1789. 107 indexed citations
16.
Chen, Hongyan, Yi Hu, Nonghua Lü, & Yin Zhu. (2020). Caudal type homeoboxes as a driving force in Helicobacter pylori infection-induced gastric intestinal metaplasia. Gut Microbes. 12(1). 1809331–1809331. 21 indexed citations
17.
Li, Xue-Yang, Yi Hu, Nianshuang Li, et al.. (2019). RACK1 Acts as a Potential Tumor Promoter in Colorectal Cancer. Gastroenterology Research and Practice. 2019. 1–8. 9 indexed citations
18.
Hu, Yi, Jianping Liu, Xue-Yang Li, et al.. (2019). Downregulation of tumor suppressor RACK1 by Helicobacter pylori infection promotes gastric carcinogenesis through the integrin β-1/NF-κB signaling pathway. Cancer Letters. 450. 144–154. 30 indexed citations
19.
Xie, Chuan, Jian Yi, Jing Lü, et al.. (2018). N‐Acetylcysteine Reduces ROS‐Mediated Oxidative DNA Damage and PI3K/Akt Pathway Activation Induced by Helicobacter pylori Infection. Oxidative Medicine and Cellular Longevity. 2018(1). 1874985–1874985. 87 indexed citations
20.
Shao, Jia, Linlin Xu, Limin Chen, et al.. (2017). Arl13b Promotes Gastric Tumorigenesis by Regulating Smo Trafficking and Activation of the Hedgehog Signaling Pathway. Cancer Research. 77(15). 4000–4013. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026